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Of Potions, Poisons, Polygonum and Pre-emptive Polymorphism  
Oberon:  
Fetch me that flower. The herb I show'd thee once. 
The juice of it on sleeping eyelids laid 
Will make man or woman madly dote 
Upon the next live creature that it sees. 
Fetch me this herb, 
Act 2, Scene 1: A Midsummer Night's Dream  
There are scores of references to plants and herbs in William Shakespeare’s plays; he was 
obviously very knowledgeable about their perceived effects. The secret to the highly potent 
love potion Oberon asks Puck to find, lies in the purple, yellow and white flower, ‘love-in-
idleness’, a folk name for the wild pansy (Viola tricolour). When scientists from Royal Society 
of Chemistry and Quest International put this to the test 400 years later, they concluded 
that ‘Wild pansies were noted in herbal folklore medicine. It was attributed with many 
properties, but, falling in love was probably the invention of Shakespeare’ [1]. Master 
craftsman had woven a myth into the plot with dramatic effect.  
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Over the generations, herbal remedies have remained popular, their status sustained more 
often by belief than evidence supporting efficacy. The output of ‘Chinese Materia Medica’ 
amounted to US$83.1 billion in 2012, the market growing by over 20% from the previous 
year [2]. As herbs are ‘natural’, formulations derived from them are deemed safe; there is 
neither coherence in categorisation of these products nor consistency in the regulatory 
requirements and processes internationally [3]. Irony is that irrespective of lack of robust 
evaluation of their efficacy, adverse hepatic reactions attributed to herbs are being reported 
increasingly. In a study involving 25,927 cases of drug-induced liver injury (DILI) from 
mainland China, herbal and dietary supplements were the most common group of causal 
agents accounting for 27% of these cases [4]. Another systematic review identified 
Polygonum multiflorum (PM) as the most common causative agent associated with herb-
induced liver injury [5]. 
Source of ambiguity in the properties of potions and poisons, effects of herbs and medicine 
is perhaps in the origin of species! When life expanded from sea and took to land, plants 
anchored themselves, setting roots while the animals roamed. Plants relied upon animals to 
disperse pollens and seeds, but, needed to protect themselves from mobile predators. The 
conflict that arose 300-500 million years ago led to the emergence of defensive, toxic 
chemicals in plants and accelerated the evolution of cytochrome P450 (CYP) families I-IV to 
detoxify plant metabolites in herbivorous animals first. It is estimated that at least 25% of all 
modern medications are derived from plants and many of these are metabolized by CYPs. 
Hence, it is unsurprising if similar pathogenic mechanisms underlie drug- and herb-induced 
liver injury. 
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In this issue of Hepatology, Chaopeng Li and colleagues report findings of their 
investigations into histogenetic risk factors associated with PM-DILI [6]. Initially, 27 gene loci 
within the Human leukocyte antigen (HLA) region were sequenced in 11 PM-DILI patients 
and allele frequencies were compared with that of 10,689 Han Chinese included in a 
population based database to identify an association of HLA-B*35:01 with liver injury. This 
discovery was then validated in an independent group of 15 PM-DILI cases, 33 cases of DILI 
due to other medications and 99 population based controls. In a further prospective cohort 
study, 3/8 (37.5%) of HLA-B*35:01 carriers and 3/64 (4.7%) non-carriers developed 2-fold 
elevation of alanine transaminase (ALT) confirming that individuals carrying HLA-B*35:01 
are at a higher risk of developing DILI when treated with herbal remedies containing PM.  
These studies followed good examples of translational research; discovery phase included 
well characterised cases (admittedly a small number) of DILI due to a single agent 
(Polygonum multiflorum). A combination of healthy and disease controls, from the general 
population as well as hospital-base was used to validate the association of HLA-B*35:01 
with PM-DILI. Potential application of HLA-B*35:01 testing was piloted in a prospective 
cohort to assess test’s performance characteristics. By design, the study involved one ethnic 
group and focused on histogenetic factors only, therefore, the results have to be viewed 
within such a pre-defined context. Beyond these specifics, identification of MHC class 1 
allele as a risk factor for PM-DILI indicates that adaptive immune response is a key step in 
the pathogenesis of liver injury in susceptible individuals (Figure 1). 
Liver is central to the biotransformation of a vast majority of herbal compounds as it is for 
drugs; the process generally leads to the formation of stable metabolite and their safe 
excretion. Genetic and environmental factors that influence the expression and activities of 
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the drug metabolising enzymes (phase I and II), transporters involved in the excretion 
(phase III) of these metabolites determine the rate of formation and accumulation of 
reactive metabolites. Oxidative stress induced by reactive metabolites or their covalent 
binding to cellular proteins interfering with vital cellular function can lead to hepatocellular 
injury particularly when cellular defense is impaired. Support to this hypothesis comes from 
the observations that furano diterpenoids in Germander (Teucrium chamaedrys) are 
oxidized by CYP3A into reactive metabolites and pyrrole-protein adducts have been 
detected in a patient with hepatic sinusoidal occlusion syndrome secondary to Chinese 
medicine ‘Tusanqi’ containing ‘Gynura segetum’. Further, those who drink germander tea 
for a long period of time have anti-microsomal epoxide hydrolase autoantibodies in their 
sera. Therefore, these herb specific events may form essential steps in the pathogenesis, 
but, not always sufficient to generate clinically significant DILI.  
HLA molecules are central to the activation of T-cells, responsible for initiating the 
inappropriate immune response that underlies DILI; both branches of the highly specific 
adaptive immune response rely on the selective presentation of antigens to T-cells by HLAs, 
highly polymorphic proteins also known as major histocompatibility complex (MHC) 
proteins. MHC class I molecules are expressed by almost all nucleated cells including 
hepatocytes. MHC class I proteins usually associate with peptide antigens generated by the 
partial degradation of self-proteins which could include metabolite-cellular protein adducts 
generated by a herbal compound. The MHC I-antigen complex is then expressed on the cell 
surface and elicits an immune response if a non-self-antigen is recognised, causing the 
activation of CD8+ T-cells, which leads to the cell mediated killing of the original cell (Figure 
1). Recently, a polymorphism in the protein tyrosine phosphatase non-receptor type 22 
gene (PTPN22) coding for lymphoid protein tyrosine phosphatase (Lyp) has been associated 
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with DILI caused by multiple drugs [7]. Switch in function associated with variant allele 
reduces immune tolerance of T-cells promoting auto-immunity. Interestingly, specific minor 
PTPN22 allele is virtually absent in Asian and African populations. 
HLA alleles have been shown to identify the risk of DILI from over 15 currently used 
medications [8] and now a herb has joined the list; time has come to use HLA genotyping as 
a part of our diagnostic armamentarium. Effective prevention of DILI using genetic markers 
would be the ultimate goal of pharmacogenetics and has been put forward in relation to 
lumiracoxib in the past [10]. As with lumiracoxib, the effectiveness of such an approach 
relies upon the added value a particular compound brings to the existing therapeutics. As 
authors propose, if pre-prescription screening for HLA-B*35:01 were to be performed in 72 
individuals, 50% (3/6) PM-DILI (based on doubling of ALT) would be prevented and 7% 
(5/72) of others carrying HLA-B*35:01 (false positive) would not be offered herbal remedy. 
However, such arguments must be tempered with caution as important evidence for health 
benefits from a number of herbs such as Polygonum multiflorum is lacking. That is a 
metaphorical green elephant in the room! 
 
Figure legend: 
Figure 1: Putative mechanisms underlying the pathogenesis of liver injury due to drugs and 
herbs. Agent (drug/ herb) specific factors influence the proximal events and distal events are 
determined by host (genetic) factors. 
Foot notes: HLA: Human Leukocyte Antigen; MHC: Major Histocompatibility Complex, CD8+: 
Cytotoxic T lymphocytes; PTPN22: protein tyrosine phosphatase non-receptor type 22 gene; 
Lyp: lymphoid protein tyrosine phosphatase.     
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